Showing all news

MRC Technology appoints Finance Director

MRC Technology has appointed Andrew Mercieca as its Finance Director from 1 April 2015. Andrew joined the company as Interim Finance Director in August 2014.

17 April 2015

Immunotherapy: boosting your body to fight cancer

The basic idea behind immunotherapy for cancer is to stimulate the body’s immune system to attack a cancer rather than the drug directly targeting the diseased cells. Antibodies such as Herceptin, for example, direct a specific attack on cancerous breast cells but a new generation of antibody drugs can also mediate this immunotherapy approach.

10 March 2015

Respiratory ‘Call for Targets’ launched

‘Call for targets’ launched to find new therapeutic concepts for treatment of respiratory disease, including conditions such as allergy, acute respiratory distress syndrome (ARDS), asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, and cystic fibrosis.

2 March 2015

Posters presented at Pharmacology 2014

‘A novel high throughput assay to identify activators of the two-pore domain potassium channel TRESK’ and ‘Identification of small molecule melanocortin 2 receptor antagonists as potential therapeutics for Cushing’s disease’.

19 January 2015
Showing all news